Charles Schwab Investment Management »

C4 Therapeutics shares owned by Charles Schwab Investment Management

Quarter-by-quarter ownership of C4 Therapeutics (CCCC) shares owned by Charles Schwab Investment Management from 13F filings

Historical chart of Charles Schwab Investment Management investment in C4 Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including C4 Therapeutics held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in C4 Therapeutics by Charles Schwab Investment Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $2.8M 483k 5.70
2024-06-30 $2.3M 489k 4.62
2024-03-31 $2.2M 267k 8.17
2023-12-31 $1.4M 253k 5.65
2023-09-30 $462k 248k 1.86
2023-06-30 $635k 231k 2.75
2023-03-31 $995k 317k 3.14
2022-12-31 $2.1M 357k 5.90
2022-09-30 $3.1M 352k 8.77
2022-06-30 $2.1M 273k 7.54
2022-03-31 $6.6M 273k 24.26
2021-12-31 $8.5M 265k 32.20
2021-09-30 $12M 261k 44.68
2021-06-30 $5.3M 141k 37.85
2021-03-31 $2.6M 70k 37.00
2020-12-31 $2.2M 67k 33.14